Production of Antimicrobial Peptides in Nicotiana benthamiana Plants for Efficient Treatments
ISEF · 2025 Plant Sciences
Overview
Antibiotic-resistant infections are projected to cause over 39 million global deaths between 2025 and 2050, with treatment costs exceeding $66 billion annually. Rather than replacing ineffective antibiotics, it is possible to restore them. Plant-produced antimicrobial peptides (AMPs) offer a promising yet untapped synergistic treatment. However, the absence of critical pre-clinical evaluations has hindered AMP’s clinical translation. This study aims to express AMPs in Nicotiana benthamiana using a tobacco mosaic virus (TMV) vector for evaluation of purity, antibacterial, cytotoxicity, and synergistic properties. A TMV-AMP plasmid was inserted into agrobacteria for agroinfiltration into N. benthamiana. After TMV-AMP plant infection, AMPs were purified via RP-HPLC. AMP viability was assessed via PCR, an antibacterial assay on E. coli MG1655, a cytotoxicity assay on human embryonic kidney (HEK) and human dermal fibroblast (HDF) cells, and a synergy assay combining AMPs with azithromycin against resistant E. coli PI-7. AMPs exhibited antibacterial activity against E. coli MG1655, with a minimum inhibitory concentration of 50 µg/mL, achieving 92.46% ± 4.53 bacterial inhibition. AMPs showed minimal cytotoxicity to HEK and HDF, maintaining >90% cell viability up to 50 µg/mL. The optimal AMP concentration for minimal cytotoxicity and maximal antibacterial activity was 50 µg/mL, with a final plant-produced yield of 2.1 mg/mL, the highest reported for plant-TMV expression. AMPs enhanced azithromycin’s efficacy against E. coli PI-7; a combination costing less than 1 cent per dose. This study highlights the potential of clinically translating AMPs as a cost-effective and clinically viable treatment to restore antibiotic efficacy, potentially saving lives by 2050.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2024
Utilizing Tobacco Mosaic Virus as a Viral Vector in the in Planta Production of Antimicrobial Peptides
ISEF · 2017
Self-Derived Peptides: Inhibition of Bacterial Growth Without Resistance
ISEF · 2021
A Multi-Factor Study Deriving a Comprehensive Evaluation of Natural Antibiotic Hybrids Bound to Novel Nanoreactors in an Inorganic Model of an Enterococcus faecalis Infected Jejunum Cross-Analyzed through Static Biofilm Production and Quorum Sensing (Year 5)
ISEF · 2025
A Novel Synergistic Approach: Combining AMOX Antibiotic or Kigelia Extracts With AgZn NPs as a Potent and Efficient Strategy to Combat Antibiotic-resistant Bacteria
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair